Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.
作者信息
Menezes-Rodrigues Francisco Sandro, Padrão Tavares José Gustavo, Pires de Oliveira Marcelo, Guzella de Carvalho Rafael, Ruggero Errante Paolo, Omar Taha Murched, José Fagundes Djalma, Caricati-Neto Afonso
机构信息
Autonomic and Cardiovascular Pharmacology Lab, Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
School of Medicine, União Metropolitana para o Desenvolvimento da Educação e da Cultura (UNIME), Lauro de Freitas, Brazil.
出版信息
J Thromb Haemost. 2020 Aug;18(8):2073-2075. doi: 10.1111/jth.14902.
Abstract
摘要
相似文献
1
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.
J Thromb Haemost. 2020 Aug;18(8):2073-2075. doi: 10.1111/jth.14902.
2
Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.
Thromb Res. 2020 Nov;195:226-227. doi: 10.1016/j.thromres.2020.08.010. Epub 2020 Aug 9.
3
The versatile heparin in COVID-19.
J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.
4
Potential of heparin and nafamostat combination therapy for COVID-19.
J Thromb Haemost. 2020 Jun;18(6):1521-1522. doi: 10.1111/jth.14858. Epub 2020 May 6.
5
Differentiating biochemical from clinical heparin resistance in COVID-19.
J Thromb Thrombolysis. 2020 Nov;50(4):1015-1016. doi: 10.1007/s11239-020-02259-5.
6
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):262-264. doi: 10.1093/ehjcvp/pvaa048.
7
Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin.
Sao Paulo Med J. 2020 Jul-Aug;138(4):349-351. doi: 10.1590/1516-3180.2020.0221.r2.22072020.
8
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
9
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.
Intern Emerg Med. 2020 Aug;15(5):751-753. doi: 10.1007/s11739-020-02331-1. Epub 2020 Apr 15.
10
Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".
J Thromb Haemost. 2020 Jun;18(6):1519-1520. doi: 10.1111/jth.14852. Epub 2020 May 6.
引用本文的文献
1
Anticoagulant therapy in COVID-19: A narrative review.
Clin Transl Sci. 2023 Sep;16(9):1510-1525. doi: 10.1111/cts.13569. Epub 2023 Jun 30.
2
Pharmacological Modulation by Low Molecular Weight Heparin of Purinergic Signaling in Cardiac Cells Prevents Arrhythmia and Lethality Induced by Myocardial Infarction.
J Cardiovasc Dev Dis. 2023 Feb 27;10(3):103. doi: 10.3390/jcdd10030103.
3
TEG, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy.
J Clin Med. 2021 Nov 18;10(22):5381. doi: 10.3390/jcm10225381.
4
Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy.
Life (Basel). 2021 Sep 30;11(10):1032. doi: 10.3390/life11101032.
5
Acute upper limb arterial ischemia in patients diagnosed with COVID-19: case series.
J Vasc Bras. 2021 Jun 16;20:e20200234. doi: 10.1590/1677-5449.200234.
6
COVID-19 diagnosis in a patient with critical limb ischemia: complications and clinical outcomes.
J Vasc Bras. 2020 Sep 21;19:e20200071. doi: 10.1590/1677-5449.200071.
7
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.
Front Mol Biosci. 2021 Jun 11;8:649575. doi: 10.3389/fmolb.2021.649575. eCollection 2021.
8
Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property.
Phytother Res. 2021 Aug;35(8):4246-4257. doi: 10.1002/ptr.7084. Epub 2021 Apr 4.
9
Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?
Phytomedicine. 2021 May;85:153396. doi: 10.1016/j.phymed.2020.153396. Epub 2020 Oct 28.
10
Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms.
Front Hum Neurosci. 2020 Nov 12;14:595567. doi: 10.3389/fnhum.2020.595567. eCollection 2020.
本文引用的文献
1
Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series.
Front Physiol. 2020 Oct 19;11:573044. doi: 10.3389/fphys.2020.573044. eCollection 2020.
2
Cardiac and arrhythmic complications in patients with COVID-19.
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008. doi: 10.1111/jce.14479. Epub 2020 Apr 13.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
5
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.
Pharmacol Res. 2019 Jul;145:104257. doi: 10.1016/j.phrs.2019.104257. Epub 2019 May 2.
6
The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin.
Immunity. 2019 Apr 16;50(4):1033-1042.e6. doi: 10.1016/j.immuni.2019.03.003. Epub 2019 Mar 26.
7
Heparin Oligosaccharides Have Antiarrhythmic Effect by Accelerating the Sodium-Calcium Exchanger.
Front Cardiovasc Med. 2018 Jun 7;5:67. doi: 10.3389/fcvm.2018.00067. eCollection 2018.
8
A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.
J Med Toxicol. 2015 Sep;11(3):326-41. doi: 10.1007/s13181-015-0465-0.
9
Mechanisms of drug-induced proarrhythmia in clinical practice.
World J Cardiol. 2013 Jun 26;5(6):175-85. doi: 10.4330/wjc.v5.i6.175.
Zotero 插件